1. Brown, M. A. et al. Hypertensive disorders of pregnancy: ISSHP classifcation, diagnosis, and management recommendations for international practice. Hypertension 72, 24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803 (2018).
2. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343, 619–629 (1994).
3. Lykke, J. A., Paidas, M. J. & Langhof-Roos, J. Recurring complications in second pregnancy. Obstet. Gynecol. 113, 1217–1224. https://doi.org/10.1097/AOG.0b013e3181a66f2d (2009).
4. van Oostwaard, M. F. et al. Prediction of recurrence of hypertensive disorders of pregnancy between 34 and 37 weeks of gestation: A retrospective cohort study. BJOG 119, 840–847. https://doi.org/10.1111/j.1471-0528.2012.03312.x (2012).
5. Ebbing, C., Rasmussen, S., Skjaerven, R. & Irgens, L. M. Risk factors for recurrence of hypertensive disorders of pregnancy, a population-based cohort study. Acta Obstet. Gynecol. Scand. 96, 243–250. https://doi.org/10.1111/aogs.13066 (2017).
6. Stuart, J. J. et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: An observational cohort study. Ann. Intern. Med. 169, 224–232. https://doi.org/10.7326/m17-2740 (2018).
7. Haug, E. B. et al. Association of conventional cardiovascular risk factors with cardiovascular disease afer hypertensive disorders of pregnancy: Analysis of the nord-trondelag health study. JAMA Cardiol. 4, 628–635. https://doi.org/10.1001/jamacardio.2019. 1746 (2019).
8. Wu, R. et al. Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: A systematic review and meta-analysis. Cardiology 145, 633–647. https://doi.org/10.1159/000508036 (2020).
9. Brouwers, L. et al. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: A systematic review and meta-analysis. BJOG 125, 1642–1654. https://doi.org/10.1111/1471-0528.15394 (2018).
10. Teilen, L. H. et al. Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am. J. Obstet. Gynecol. 219, 107e101-107e106. https://doi.org/10.1016/j.ajog.2018.04.002 (2018).
11. American College of, O., Gynecologists & Society for Maternal-Fetal, M. Obstetric care consensus no. 8: Interpregnancy care. Obstet. Gynecol. 133, e51–e72. https://doi.org/10.1097/AOG.0000000000003025 (2019).
12. Randel, A. Interpregnancy care: Guidelines from ACOG and SMFM. Am. Fam. Physician 100, 121–123 (2019).
13. Erondu, C. & Dunlop, A. Interpregnancy care: An opportunity to improve women’s health and reduce the risk of maternal morbidity and mortality. J. Public Health Manag. Pract. 27, S155–S158. https://doi.org/10.1097/PHH.0000000000001319 (2021).
14. Hjartardottir, S., Leifsson, B. G., Geirsson, R. T. & Steinthorsdottir, V. Recurrence of hypertensive disorder in second pregnancy. Am. J. Obstet. Gynecol. 194, 916–920. https://doi.org/10.1016/j.ajog.2005.10.819 (2006).
15. Brown, M. A. et al. Can we predict recurrence of pre-eclampsia or gestational hypertension?. BJOG 114, 984–993. https://doi.org/ 10.1111/j.1471-0528.2007.01376.x (2007).
16. Teulings, N., Masconi, K. L., Ozanne, S. E., Aiken, C. E. & Wood, A. M. Efect of interpregnancy weight change on perinatal outcomes: Systematic review and meta-analysis. BMC Pregnancy Childbirth 19, 386. https://doi.org/10.1186/s12884-019-2566-2 (2019).
17. Martinez-Hortelano, J. A. et al. Interpregnancy weight change and hypertension during pregnancy: A systematic review and metaanalysis. Obstet. Gynecol. 135, 68–79. https://doi.org/10.1097/AOG.0000000000003573 (2020).
18. Williams, P. T. & Wood, P. D. Te efects of changing exercise levels on weight and age-related weight gain. Int. J. Obes. (Lond.) 30, 543–551. https://doi.org/10.1038/sj.ijo.0803172 (2006).
19. Rosell, M., Appleby, P., Spencer, E. & Key, T. Weight gain over 5 years in 21,966 meat-eating, fsh-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int. J. Obes. (Lond.) 30, 1389–1396. https://doi.org/10.1038/sj.ijo.0803305 (2006).
20. Tanamas, S. K., Shaw, J. E., Backholer, K., Magliano, D. J. & Peeters, A. Twelve-year weight change, waist circumference change and incident obesity: Te Australian diabetes, obesity and lifestyle study. Obesity (Silver Spring) 22, 1538–1545. https://doi.org/ 10.1002/oby.20704 (2014).
21. Bovend’Eerdt, T. J., Botell, R. E. & Wade, D. T. Writing SMART rehabilitation goals and achieving goal attainment scaling: A practical guide. Clin. Rehabil. 23, 352–361. https://doi.org/10.1177/0269215508101741 (2009).
22. Park, S. L. et al. Body size, adult BMI gain and endometrial cancer risk: Te multiethnic cohort. Int. J. Cancer 126, 490–499. https:// doi.org/10.1002/ijc.24718 (2010).
23. Muskens, I. S. et al. Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: Te Multiethnic Cohort. Neuro Oncol. 21, 498–507. https://doi.org/10.1093/neuonc/noz005 (2019).
24. Gong, W. et al. Efects of longitudinal body mass index variability on microvasculature over 5 years in adult Chinese. Obesity (Silver Spring) 24, 743–749. https://doi.org/10.1002/oby.21398 (2016).
25. Sun, J. et al. Sleep duration and cardiovascular risk factors in children and adolescents: A systematic review. Sleep Med. Rev. 53, 101338. https://doi.org/10.1016/j.smrv.2020.101338 (2020).
26. Johnson, R. F. et al. Weight gain velocity as a predictor of severe obstructive sleep apnea among obese adolescents. Laryngoscope 130, 1339–1342. https://doi.org/10.1002/lary.28296 (2020).
27. Alderisio, A. et al. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study. Nutr. Metab. Cardiovasc. Dis. 29, 1110–1117. https://doi.org/10.1016/j. numecd.2019.06.008 (2019).
28. Polemiti, E. et al. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: Te EPIC-Potsdam study. Diabetologia 64, 814–825. https://doi.org/10.1007/s00125-020-05362-7 (2021).
29. Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163. https://doi.org/10.1016/s0140-6736(03)15268-3 (2004).
30. Sorbye, L. M. et al. Interpregnancy weight change and recurrence of gestational diabetes mellitus: A population-based cohort study. BJOG 127, 1608–1616. https://doi.org/10.1111/1471-0528.16364 (2020).
31. Takeuchi, A. et al. Neurodevelopment in full-term small for gestational age infants: A nationwide Japanese population-based study. Brain Dev. 38, 529–537. https://doi.org/10.1016/j.braindev.2015.12.013 (2016).
32. Cormick, G. et al. Inter-pregnancy interval and risk of recurrent pre-eclampsia: Systematic review and meta-analysis. Reprod. Health 13, 83. https://doi.org/10.1186/s12978-016-0197-x (2016).
33. Gebremedhin, A. T. et al. Interpregnancy interval and hypertensive disorders of pregnancy: A population-based cohort study. Paediatr. Perinat. Epidemiol. 35, 404–414. https://doi.org/10.1111/ppe.12668 (2021).
34. American College of, N.-M. et al. Interpregnancy care. Am. J. Obstet. Gynecol. 220, 22–18. https://doi.org/10.1016/j.ajog.2018.11. 1098 (2019).
35. Hartman, S., Brown, E., Holub, D., Horst, M. & Loomis, E. Optimizing interconception care: Rationale for the IMPLICIT model. Semin. Perinatol. 44, 151247. https://doi.org/10.1016/j.semperi.2020.151247 (2020).
36. Dude, A. M. et al. Weight gain in early, mid, and late pregnancy and hypertensive disorders of pregnancy. Pregnancy Hypertens. 20, 50–55. https://doi.org/10.1016/j.preghy.2020.03.001 (2020).
37. Ohta, K. et al. Association between a variant of the glutathione S-transferase P1 gene (GSTP1) and hypertension in pregnancy in Japanese: Interaction with parity, age, and genetic factors. Semin. Tromb. Hemost 29, 653–659. https://doi.org/10.1055/s-2004- 815636 (2003).
38. Kobashi, G. et al. A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J. Hum. Genet. 49, 182–186. https://doi.org/10.1007/s10038-004-0129-4 (2004).
39. Langenveld, J. et al. Recurrence risk of a delivery before 34 weeks of pregnancy due to an early onset hypertensive disorder: A systematic review. Am. J. Perinatol. 27, 565–571. https://doi.org/10.1055/s-0030-1248944 (2010).
40. Kirkegaard, H. et al. Maternal weight change from prepregnancy to 18 months postpartum and subsequent risk of hypertension and cardiovascular disease in Danish women: A cohort study. PLoS Med. 18, e1003486. https://doi.org/10.1371/journal.pmed. 1003486 (2021).